The closing price of Cabaletta Bio Inc (NASDAQ: CABA) was $16.98 for the day, up 5.40% from the previous closing price of $16.11. In other words, the price has increased by $+0.87 from its previous closing price. On the day, 980350 shares were traded.
Ratios:
Our analysis of CABA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.29 and its Current Ratio is at 15.29. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On November 29, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $38.
On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $40.Cantor Fitzgerald initiated its Overweight rating on October 24, 2023, with a $40 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 19 ’24 when Binder Gwendolyn sold 11,000 shares for $19.59 per share. The transaction valued at 215,439 led to the insider holds 20,000 shares of the business.
Binder Gwendolyn sold 11,000 shares of CABA for $240,789 on Dec 19 ’23. The insider now owns 20,000 shares after completing the transaction at $21.89 per share. On Nov 20 ’23, another insider, Binder Gwendolyn, who serves as the insider of the company, sold 11,000 shares for $17.82 each. As a result, the insider received 196,014 and left with 20,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 820.11M and an Enterprise Value of 583.88M.
Stock Price History:
Over the past 52 weeks, CABA has reached a high of $26.35, while it has fallen to a 52-week low of $7.43. The 50-Day Moving Average of the stock is 20.94, while the 200-Day Moving Average is calculated to be 17.07.
Shares Statistics:
CABA traded an average of 941.67K shares per day over the past three months and 1.03M shares per day over the past ten days. A total of 47.82M shares are outstanding, with a floating share count of 33.75M. Insiders hold about 21.23% of the company’s shares, while institutions hold 96.32% stake in the company. Shares short for CABA as of Mar 15, 2024 were 7.09M with a Short Ratio of 7.53, compared to 6.83M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 14.70% and a Short% of Float of 16.41%.
Earnings Estimates
The firm’s stock currently is rated by 10 analysts. On average, analysts expect EPS of -$0.48 for the current quarter, with a high estimate of -$0.31 and a low estimate of -$0.66, while EPS last year was -$0.45. The consensus estimate for the next quarter is -$0.47, with high estimates of -$0.3 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.25 and -$2.29 for the fiscal current year, implying an average EPS of -$1.9. EPS for the following year is -$2.09, with 11 analysts recommending between -$0.94 and -$2.84.
